This situation prompted us to evaluate several RET assays (i.e., RNA-based NGS as criterion standard method, FISH, and RT-PCR) in a large multicenter cohort of RET-positive NSCLC to obtain real-world data. Here, RET is linked to non-small cell lung carcinoma.